Medicare, Medicaid & Private Payor Updates

House Seeks to Defund the WISeR Program – Providers Won’t See Relief Any Time Soon - Featured Image - Liles Parker NEW

House Seeks to Defund the WISeR Program – Providers Won’t See Relief Any Time Soon

Medicare, Medicaid & Private Payor Updates /

(June 23, 2026): This week, the U.S. House of Representatives’ Appropriations Committee approved draft Fiscal Year (FY) 2027 appropriations language covering the Department of Health and Human Services (HHS). If ultimately enacted, this appropriations language will bar the use of federal funds to implement the Centers for Medicare & Medicaid Services’ (CMS) “Wasteful and Inappropriate […]

House Seeks to Defund the WISeR Program – Providers Won’t See Relief Any Time Soon Read More »

Staying Ahead of the Surge in Medicare Revocation Actions - Featured Image - Liles Parker

Staying Ahead of the Surge in Medicare Revocation Actions

Medicare, Medicaid & Private Payor Updates /

(April 13, 2026): Physicians, home health agencies, and hospices constantly strive to ensure the well-being of their patients. Unfortunately, over the past few years, scores of providers have found themselves at odds with the Centers for Medicare & Medicaid Services (CMS) and its contractors. If you think “It Can’t Happen to Me,” consider this –

Staying Ahead of the Surge in Medicare Revocation Actions Read More »

Transcranial Doppler Claims are Being Audited - Featuered Image - Liles Parker

Transcranial Doppler Claims are Being Audited. Are You Ready?

Medicare, Medicaid & Private Payor Updates /

(February 2, 2026): Neurologists, radiologists, and vascular surgeons around the country who perform Transcranial Doppler Ultrasound procedures are currently under the government’s regulatory microscope. Therefore, it is more important than ever that you review your business practices to confirm your transcranial doppler procedures fully meet applicable medical necessity, documentation, coding, and billing requirements. As discussed

Transcranial Doppler Claims are Being Audited. Are You Ready? Read More »

Responding to Medicare Audits of PCR Testing for UTIs in 2026 - Liles Parker

Responding to Medicare Audits of PCR Testing for UTIs in 2026

Medicare, Medicaid & Private Payor Updates /

(December 18, 2025): Laboratory Polymerase Chain Reaction (PCR) testing for urinary tract infections (UTIs) offers rapid, sensitive pathogen detection but often presents complex coding and billing challenges for Medicare providers and laboratories. Medicare contractors are increasingly denying UTI test claims due to issues with medical necessity, documentation, and improper coding/billing practices. Robust compliance and up-to-date

Responding to Medicare Audits of PCR Testing for UTIs in 2026 Read More »

Wound care aukdit and skin substitute audit 2026 - Featured Image - Liles Parker

Responding to Wound Care Audits and Skin Substitute Audits in 2026

Medicare, Medicaid & Private Payor Updates, Other /

CMS UPDATE – DECEMBER 24, 2025 “Effective immediately, CMS’ A/B Medicare Administrative Contractors (MACs) are withdrawing the Local Coverage Determinations (LCDs) for Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers that were scheduled to become effective on January 1, 2026.” ORIGINAL ARTICLE (December 11, 2025): In 1789,

Responding to Wound Care Audits and Skin Substitute Audits in 2026 Read More »

Prior Authorization Audits for Certain ASC Services in 2026 - Featured Image - Liles Parker

Prior Authorization Demonstration Audits for Certain ASC Services Start in January 2026

Medicare, Medicaid & Private Payor Updates /

(December 09, 2025): The Government Accountability Office (GAO) has long expressed concerns regarding the fraud, waste and abuse risks inherent in the Medicare program. In fact, GAO first designated Medicare as a “High Risk” program due to its size, complexity and susceptibility to improper payments.[1] Throughout 2025, Medicare providers and suppliers were subjected to significant

Prior Authorization Demonstration Audits for Certain ASC Services Start in January 2026 Read More »

Wasteful and Inappropriate Service Reduction (WISeR) Model - Liles Parker

Overview of the WISeR Model: How Should Your Practice Respond?

Medicare, Medicaid & Private Payor Updates /

(September 25, 2025): Medicare providers and beneficiaries will likely face a number of new challenges over the next five years. As you will recall, the Centers for Medicare and Medicaid Services (CMS) Innovation Center has set a goal of having 100% of Traditional Medicare (also commonly referred to as “Original Medicare”) beneficiaries move over to

Overview of the WISeR Model: How Should Your Practice Respond? Read More »

Ketamine Audits and Investigations are on the Rise - Featured Image

Ketamine Audits and Investigations are on the Rise! Are Your Ketamine Infusion / Injection Practices Compliant with the Law?

Medicare, Medicaid & Private Payor Updates /

(October 10, 2024): Ketamine has been in the news again lately. . . for all the wrong reasons. In August 2024, Federal prosecutors out of the Central District of California announced the indictment of five individuals, including two physicians, who allegedly played a role in the fatal ketamine overdose of Matthew Perry in October 2023.

Ketamine Audits and Investigations are on the Rise! Are Your Ketamine Infusion / Injection Practices Compliant with the Law? Read More »

Amniotic Membrane - Featured Image - Liles Parker

Navigating Amniotic Tissue / Amniotic Membrane / Skin Substitute Audits and Investigations

Medicare, Medicaid & Private Payor Updates, Other /

(August 14, 2024): For almost a century, health care providers have used amniotic tissues / amniotic membranes in the care and treatment of wounds.[1] In recent years, health care providers have greatly expanded the scope of therapeutic applications employing amniotic tissues / amniotic membranes in wound care procedures. These developments have led to increased scrutiny

Navigating Amniotic Tissue / Amniotic Membrane / Skin Substitute Audits and Investigations Read More »

Health Care Provider Risks of Chelation Therapy - Liles Parker

Health Care Provider Risks When Ordering and Billing Chelation Therapy Services

Medicare, Medicaid & Private Payor Updates /

(January 25, 2024): Although chelation therapy[1] has played an important role in mainstream medicine for many years,[2] it is still considered by many clinicians and regulators to fall within the category of “Complementary and Alternative Medicine.” Proponents of chelation therapy in alternative medicine practices have supported its use in treating Alzheimer’s disease,[3] Parkinson’s disease, multiple

Health Care Provider Risks When Ordering and Billing Chelation Therapy Services Read More »